Patent · US Active

Antibodies against notch 3

US10538587B2 · kind B2 · utility

0Cited by

9References

6Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Joelle Deplazes-Lauber · Planegg, DE
Christy FRYER · Cambridge, US
Tiacen Hu · Cambridge, US
David Jenkins · Waltham, US
Konstantin Petropoulos · Munich, DE
Philippe Thiel · Planegg, DE

Key dates

Filing date	Sep 14, 2015
Grant date	Jan 21, 2020
Priority date	—
Expiry date	Sep 14, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/7028
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to antibodies or fragments thereof that target at least one conformational epitope of a Notch 3 or mutant Notch 3 receptor; and compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.